IPOs - Page 43 | TalkMarkets

Content

All Posts > Content under IPOs
673 to 688 of 1833 Posts
<<< 1 ... 41 42 43 44 45 ... 115 >>>
It's Not A Good Time To Start A Business
Article By: Mish Shedlock
Saturday, February 15, 2020 7:03 PM EDT
The Bloomberg Startup Barometer, a measure of business environment health, is in a steep plunge. The Bloomberg Startups Index is down 25.45% from a year ago, but it's down a massive 46.0% in just under 7 months.
Read
Week In Review: Bio-Thera Raises $241 Million In Shanghai STAR IPO For Antibody Portfolio
Article By: ChinaBio® Today
Saturday, February 15, 2020 4:19 PM EDT
Bio-Thera Solutions of Guangzhou priced its IPO on Shanghai’s STAR Board to raise $241 million at a valuation of almost $2 billion. The offering, which placed 60 million shares at RMB32.76 each, was reported to be 3,225 times oversubscribed.
In this article: JNJ, ROG, GILD, ZLAB
Read
IPOs Could Become A Huge Part Of The Crypto Industry
Article By: TotalCrypto
Thursday, February 13, 2020 11:27 PM EDT
Cryptocurrencies and blockchain technology are going through a transition period. The time of novelty and skepticism has come to an end but now there are other, bigger issues at hand.
In this article: XRP-X
Read
Airbnb IPO In Peril After Unexpected Loss, Coronavirus Fears
Article By: Tyler Durden
Wednesday, February 12, 2020 5:20 AM EDT
The coronavirus outbreak in China could derail Airbnb Inc.'s attempt to going public in the next several quarters.
Read
Opening Day: Casper Jumps In First Day, Then Sinks Below IPO Price
Article By: The Fly
Sunday, February 9, 2020 2:11 PM EDT
After lowering its share price target range by 30% the day before, Casper Sleep (CSPR​) opened on Thursday at $14.50 only to see a significant bump in early trading, with the online mattress maker's stock jumping by as much as 29%.
In this article: CSPR, BEAM, SDGR
Read
Week In Review: AkesoBio Files For $300 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, February 8, 2020 4:16 PM EDT
AkesoBio, a Zhongshan novel drug discovery and development biopharma, filed for a $300 million Hong Kong IPO to develop its portfolio of novel mono- and bi-specific antibodies.
In this article: ZLAB, GILD
Read
Casper Makes Wall Street Debut
Article By: Benzinga
Thursday, February 6, 2020 11:36 AM EDT
Casper made its public debut Thursday morning, opening at $14.50 after being priced at $12 per share.
In this article: CSPR
Read
Don’t Let Casper’s Lower Price Fool You, It’s Still Overvalued
Article By: David Trainer
Thursday, February 6, 2020 3:00 AM EDT
When Casper (CSPR) first filed for IPO, it was aiming for a valuation as high as $768 million.
In this article: CSPR Also: TPX, WMT, OSTK, AMZN, BBBY, W, SNBR, PRPL
Read
Percent Of Money-Losing IPOs As High As 2000 Tech Bubble Peak
Article By: Harry Dent
Sunday, February 2, 2020 5:31 PM EDT
81% of the IPOs in 2018 were profitless – the highest since 2000 also at 81%. Such questionable IPOs always appear near speculative tops like this one.
In this article: UBER, AAPL, AMZN, GOOG, NFLX, META, GOOGL
Read
Opening Day: Black Diamond Jumps In First Day Of Trading
Article By: The Fly
Sunday, February 2, 2020 1:50 PM EDT
Black Diamond Therapeutics (BDTX) opened for trading way above the price of $19, raising $201M from its IPO to advance its cancer drug research and development.
Read
Telco IPO Is Only One Way To Paint Africa Orange
Article By: Lipper Alpha Insight
Wednesday, January 22, 2020 8:40 AM EDT
French telecoms group Orange faces a tough call on floating its African unit. Listing a chunk of the business, which could be worth 13 billion euros, would raise some cash and potentially boost the company’s valuation.
Read
WeWork's Lease Activity Crashed 93% In 4Q After Failed IPO
Article By: Tyler Durden
Sunday, January 19, 2020 2:38 PM EDT
Several months after WeWork’s failed IPO the office-sharing company leased just four new sites for a combined 184,00 sq. Ft. of space in 4Q19, marking a 93% plunge from its quarterly average rate of 2.54 million sq. ft. over the last four quarters.
In this article: WE, SFTBY
Read
Week In Review: China's I-Mab Stages $104 Million Nasdaq IPO
Article By: ChinaBio® Today
Saturday, January 18, 2020 2:34 PM EDT
I-Mab, a Shanghai biotech, raised $104 million in its IPO on the Nasdaq exchange to support its portfolio of biologic products.The offering was priced at $14 per ADS but the price has moved 10% lower to $12.58 in initial trading.
In this article: PFE, ROG, CHRS, BGNE
Read
Castle Could Crumble When IPO Lockup Expires
Article By: Don Dion
Friday, January 17, 2020 9:40 AM EDT
When the IPO lockup period for CSTL expires on January 21st, pre-IPO shareholders and company insiders will be able to sell more than 10 million currently restricted shares.
In this article: CSTL Also: AZN, BMY, JNJ, LLY, MRK, NVS, AMGN, ABBV
Read
Health Catalyst Could Slump When Lockup Expires
Article By: Don Dion
Thursday, January 16, 2020 12:11 PM EDT
When the 180-day lockup period for Health Catalyst Inc. expires on January 21, 2020, the company's pre-IPO shareholders and insiders may choose to sell more than 28 million shares in the secondary market.
In this article: HCAT Also: IBM, SAP, TG, AMZN, GOOG, MSFT, SPLK, EVH, CHNG
Read
Are Ridesharing Stocks About To LYFT Off?
Article By: Investing Whisperer
Thursday, January 9, 2020 9:57 PM EDT
UBER and LYFT are two disruptive leaders, like Facebook, that also stumbled badly in the public markets after their IPO. They bled cash profusely in their first couple quarterly reports. But clearly, things are changing.
In this article: LYFT, UBER Also: META
Read
673 to 688 of 1833 Posts
<<< 1 ... 41 42 43 44 45 ... 115 >>>